AJA 005
Alternative Names: AJA-005Latest Information Update: 01 Mar 2024
At a glance
- Originator AJNA Biosciences
- Class Sleep disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Sleep disorders
Most Recent Events
- 18 Dec 2023 Early research in Sleep disorders in USA prior to December 2023 (unspecified route) (AJNA Biosciences pipeline, December 2023)